By Daniel Shortt, Attorney at Harris Bricken The Agriculture Improvement Act of 2018 (2018 Farm Bill) legalized hemp by removing the crop and its derivatives from the definition of marijuana under the Controlled Substances Act (CSA) and by providing a detailed framework for the cultivation of hemp. The 2018 Farm Bill gives the US Department […]
FDA
Government Agencies Approve MMJ’s Import of Marijuana for Research
PRESS RELEASE ST.PETERSBURG, FL / ACCESSWIRE / May 21, 2020 / Multiple government agencies have cooperated to allow MMJ International Holdings to import cannabis extracts to the United States, for use in potential therapies the company is developing for clinical trials in Huntington’s disease and multiple sclerosis. The cannabis plant makes numerous compounds called cannabinoids, […]
What’s on the mind of potential CBD consumers?
While the industry continues to weigh the impact of the latest shake-up by the FDA, potential adopters of CBD among non-users continue to eye the growing multitude of cannabidiol-infused products with interest and trepidation. For example, the warning letters issued in late November caused a stir in the industry – and may have had a […]
Charlotte’s Web Faces Class Action Lawsuit for Improperly Marketing CBD Products
By Alison Malsbury Attorney at Harris Bricken We’ve written extensively about hemp-derived CBD and the myriad issues faced by manufacturers CBD edibles. You can read more about this topic here: Is Hemp CBD Really Unlawful in California? The FDA Issues Hemp-CBD Warning Letters and a Consumer Update Litigation Update: JustCBD Files Motion to Dismiss Class Action […]
New York to subpoena firms selling substances linked to illicit vaping products
New York Gov. Andrew M. Cuomo (D) said Monday he is ordering the state health department to issue subpoenas to three companies the department has identified as selling substances linked to the mysterious vaping-related lung illnesses that have sickened hundreds of people across the country. The companies are marketing and selling “thickening agents” that can […]
FDA warns top marijuana company for making CBD health claims
U.S. regulators warned a leading marijuana company for making unproven health claims about CBD, the trendy ingredient that’s turning up in lotions, foods and pet treats. The Food and Drug Administration announced Tuesday it warned Curaleaf Inc., of Wakefield, Massachusetts, for illegally selling unapproved products. Curaleaf’s claims could lead people to delay medical care for […]
North Carolina proposes smokable hemp ban as demand grows
CLIMAX, N.C. — North Carolina is the latest state considering a ban on smokable hemp, a product that’s exploding along with the health craze surrounding a compound in the plant known as CBD. Besides federal regulations laid out in the Hemp Farming Act of 2018, the Food and Drug Administration has no additional regulations on […]
Cannabis and Hemp Industry Trembles After FDA Cracks the Whip
With the FDA “locked and loaded,” and billions of annual sales and “deal flow capital” hanging in the balance, the cannabis and hemp industries are questioning whether their products can be manufactured, sold and marketed without vending adulterated or misbranded food, drugs and cosmetics, or making false or unsubstantiated health claims. By Steve Schain Powered […]
Market Confusion on CBD and Hemp; FDA Commissioner Resigns amid Congressional Pressure for Federal Guidance
By Ian Stewart & Neil Willner The Commissioner of the Food and Drug Administration (FDA), Scott Gottlieb MD, who has received high marks for his leadership of the agency since May 2017, announced his resignation on March 5, 2019, stating that he wants to spend more time with his family. His resignation came only days following […]
Understanding Potential CBD Users; Drivers to Adoption
In recent weeks, this space has seen several contributions from High Yield Insights to the ongoing conversation in the industry on cannabidiol. Dating back to a high-level review of the CBD consumer in July 2018, our approach has to evaluate the opportunities and challenges ahead for CBD through the lens of consumer insights. Most recently, […]
